Harel Gadot took the helm as Microbot Medical Inc’s (NASDAQ:MBOT) CEO and grew market cap to USD$48.45M recently. Understanding how CEOs are incentivised to run and grow their company isRead More ...

Microbot (MBOT) signs a clinical trial agreement with the Baptist Hospital of Miami for its LIBERTY Endovascular Robotic Surgical System as a part of its Investigational Device Exemption.

June 12, 2025 — 12:00 pm EDT Written by Zacks Equity Research for Zacks -> Microbot Medical Inc. (MBOT) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy).

Microbot Medical (NASDAQ: MBOT) provides us with an interesting proof concerning research and clinical stage pharma companies. For if we look at the field more widely it seems that every time there's ...

Microbot Medical's (MBOT) stock gains as its Liberty surgical robotic system achieves 100% success in trials, hitting the main goal in a pivotal trial. Read more here.

Microbot Medical Inc. MBOT recently signed a clinical trial agreement with the Baptist Hospital of Miami for its LIBERTY Endovascular Robotic Surgical System. The company has received the ...

Microbot Medical Inc. (MBOT) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates ...